B. Metzler seel. Sohn & Co’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
AIM
B. Metzler seel. Sohn & Co's RDY Position: Q1 2026 in Review
B. Metzler seel. Sohn & Co increased its Dr. Reddy's Laboratories (RDY) stake by 6% in Q1 2026, buying an estimated $288K and bringing the position to 365,485 shares worth $5.06M. The position accounts for 0.05% of the portfolio, ranked #218.
B. Metzler seel. Sohn & Co first reported a position in RDY in Q3 2021 and has held it in 19 quarters since. 248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.
- B. Metzler seel. Sohn & Co held 365,485 shares of Dr. Reddy's Laboratories worth $5.06M as of Q1 2026.
- B. Metzler seel. Sohn & Co bought 20,699 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $288K.
- Dr. Reddy's Laboratories made up 0.05% of B. Metzler seel. Sohn & Co's portfolio in Q1 2026, its #218 holding.
- B. Metzler seel. Sohn & Co first reported a position in Dr. Reddy's Laboratories in Q3 2021 and has held it in 19 quarters since.
- 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.
Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.